Vimarsana
Biggest News Aggregation in the World

Current Therapies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Current Therapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Current Therapies Today - Breaking & Trending Today

What Is Glaucoma? Types, Symptoms And Causes - Vimarsana News

What Is Glaucoma? Types, Symptoms And Causes

What Is Glaucoma? Types, Symptoms And Causes

Source: forbes.com
Johnson & Johnson : Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorization for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations - Vimarsana News

Johnson & Johnson : Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorization for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations

BEERSE, Belgium, 21 April 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission has granted marketing authorisation for AKEEGA®... | April 21, 2023

Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat - Vimarsana News

Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat

Clovis Oncology, Inc. today announced the presentation of data from the TRITON3 Phase 3 trial in men with metastatic castration-resistant prostate cancer with BRCA or ATM mutations. The presentation... | October 27, 2022

Acute Kidney Injury Market to Grow at a CAGR of Approximately 8% by 2032 - Vimarsana News

Acute Kidney Injury Market to Grow at a CAGR of Approximately 8% by 2032

/PRNewswire/ -- DelveInsight's Acute Kidney Injury Market Insights report includes a comprehensive understanding of current treatment practices, Acute Kidney...

DelveInsight Business Research, LLP: Acute Kidney Injury Market to Grow at a CAGR of Approximately 8% by 2032 - Vimarsana News

DelveInsight Business Research, LLP: Acute Kidney Injury Market to Grow at a CAGR of Approximately 8% by 2032

The dynamics of acute kidney injury market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, incremental